ResMed Inc (RMD)
Net profit margin
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 1,400,720 | 1,020,950 | 897,556 | 779,437 | 474,505 |
| Revenue | US$ in thousands | 5,146,330 | 4,685,300 | 4,222,990 | 3,578,130 | 3,196,820 |
| Net profit margin | 27.22% | 21.79% | 21.25% | 21.78% | 14.84% |
June 30, 2025 calculation
Net profit margin = Net income ÷ Revenue
= $1,400,720K ÷ $5,146,330K
= 27.22%
The net profit margin of ResMed Inc. exhibits an overall upward trajectory over the period from June 30, 2021, to June 30, 2025. Starting at 14.84% in 2021, the margin demonstrates a significant improvement by 2022, reaching 21.78%. This increase suggests enhanced profitability and potentially better cost management or revenue growth during that year. In 2023, the net profit margin slightly decreased to 21.25%, indicating a marginal contraction in profitability, which could be attributable to increased expenses or shifts in revenue composition. However, the margin resumes its upward trend in 2024, reaching 21.79%, and continues to improve markedly in 2025, achieving 27.22%. This substantial increase suggests a strong enhancement in overall profitability, possibly driven by operational efficiencies, favorable market conditions, or strategic initiatives that have effectively increased net income relative to revenues. In summary, the data reflects a positive margin trend over the analyzed period, with notable growth culminating in a significant margin expansion by June 2025.
Peer comparison
Jun 30, 2025